High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.
Saved in:
| Title: | High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis. |
|---|---|
| Authors: | Røssevold AH; Department of Clinical Cancer Research, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Tekpli X; Department of Medical Genetics, Clinic for Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Lingjærde OC; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway., Russnes HG; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway., Vallon-Christersson J; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Borgen E; Department of Pathology, Oslo University Hospital, Oslo, Norway., Lømo J; Department of Pathology, Oslo University Hospital, Oslo, Norway., Garred Ø; Department of Pathology, Oslo University Hospital, Oslo, Norway., Dorraji E; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Kristensen VN; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Medical Genetics, Clinic for Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Naume B; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Kyte JA; Department of Clinical Cancer Research, Department of Oncology, Oslo University Hospital, Oslo, Norway. jonky@ous-hf.no.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. jonky@ous-hf.no.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. jonky@ous-hf.no.; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway. jonky@ous-hf.no. |
| Source: | Communications medicine [Commun Med (Lond)] 2025 Jun 16; Vol. 5 (1), pp. 234. Date of Electronic Publication: 2025 Jun 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40523912 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Røssevold+AH%22">Røssevold AH</searchLink>; Department of Clinical Cancer Research, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Tekpli+X%22">Tekpli X</searchLink>; Department of Medical Genetics, Clinic for Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lingjærde+OC%22">Lingjærde OC</searchLink>; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Russnes+HG%22">Russnes HG</searchLink>; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Vallon-Christersson+J%22">Vallon-Christersson J</searchLink>; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Borgen+E%22">Borgen E</searchLink>; Department of Pathology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lømo+J%22">Lømo J</searchLink>; Department of Pathology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Garred+Ø%22">Garred Ø</searchLink>; Department of Pathology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Dorraji+E%22">Dorraji E</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kristensen+VN%22">Kristensen VN</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Medical Genetics, Clinic for Laboratory Medicine, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Naume+B%22">Naume B</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kyte+JA%22">Kyte JA</searchLink>; Department of Clinical Cancer Research, Department of Oncology, Oslo University Hospital, Oslo, Norway. jonky@ous-hf.no.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. jonky@ous-hf.no.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. jonky@ous-hf.no.; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway. jonky@ous-hf.no. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918250414506676%22">Communications medicine</searchLink> [Commun Med (Lond)] 2025 Jun 16; Vol. 5 (1), pp. 234. <i>Date of Electronic Publication: </i>2025 Jun 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Portfolio%22">Nature Portfolio </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918250414506676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2730-664X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222730664X%22">2730664X </searchLink><i>NLM ISO Abbreviation: </i>Commun Med (Lond) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40523912 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s43856-025-00865-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 234 Titles: – TitleFull: High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Røssevold AH – PersonEntity: Name: NameFull: Tekpli X – PersonEntity: Name: NameFull: Lingjærde OC – PersonEntity: Name: NameFull: Russnes HG – PersonEntity: Name: NameFull: Vallon-Christersson J – PersonEntity: Name: NameFull: Borgen E – PersonEntity: Name: NameFull: Lømo J – PersonEntity: Name: NameFull: Garred Ø – PersonEntity: Name: NameFull: Dorraji E – PersonEntity: Name: NameFull: Kristensen VN – PersonEntity: Name: NameFull: Naume B – PersonEntity: Name: NameFull: Kyte JA IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 06 Text: 2025 Jun 16 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2730-664X Numbering: – Type: volume Value: 5 – Type: issue Value: 1 Titles: – TitleFull: Communications medicine Type: main |
| ResultId | 1 |